MX9102516A - Metodo para fabricar liposomas de una capacidad de atrape mejorada hacia las substancias extrañas que se van a encapsular. - Google Patents

Metodo para fabricar liposomas de una capacidad de atrape mejorada hacia las substancias extrañas que se van a encapsular.

Info

Publication number
MX9102516A
MX9102516A MX9102516A MX9102516A MX9102516A MX 9102516 A MX9102516 A MX 9102516A MX 9102516 A MX9102516 A MX 9102516A MX 9102516 A MX9102516 A MX 9102516A MX 9102516 A MX9102516 A MX 9102516A
Authority
MX
Mexico
Prior art keywords
pct
encapsulated
substances
date jun
manufacturing liposomes
Prior art date
Application number
MX9102516A
Other languages
English (en)
Spanish (es)
Inventor
Michel Schneider
Herve Tournier
Roland Hyacinthe
Christian Guillot
Bernard Lamy
Original Assignee
Sint Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sint Sa filed Critical Sint Sa
Publication of MX9102516A publication Critical patent/MX9102516A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
    • A61K49/0461—Dispersions, colloids, emulsions or suspensions
    • A61K49/0466—Liposomes, lipoprotein vesicles, e.g. HDL or LDL lipoproteins, phospholipidic or polymeric micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1277—Preparation processes; Proliposomes
    • A61K9/1278—Post-loading, e.g. by ion or pH gradient

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dispersion Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Preparation (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MX9102516A 1990-12-11 1991-12-11 Metodo para fabricar liposomas de una capacidad de atrape mejorada hacia las substancias extrañas que se van a encapsular. MX9102516A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP90810969 1990-12-11

Publications (1)

Publication Number Publication Date
MX9102516A true MX9102516A (es) 1992-06-01

Family

ID=8205973

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9102516A MX9102516A (es) 1990-12-11 1991-12-11 Metodo para fabricar liposomas de una capacidad de atrape mejorada hacia las substancias extrañas que se van a encapsular.

Country Status (20)

Country Link
US (1) US5393530A (index.php)
EP (1) EP0514523B1 (index.php)
JP (1) JP3241720B2 (index.php)
KR (1) KR0137783B1 (index.php)
AT (1) ATE131724T1 (index.php)
AU (1) AU635456B2 (index.php)
CA (1) CA2072559C (index.php)
DE (1) DE69115682T2 (index.php)
DK (1) DK0514523T3 (index.php)
ES (1) ES2081605T3 (index.php)
GR (1) GR3018506T3 (index.php)
HU (1) HUT62458A (index.php)
IE (1) IE72163B1 (index.php)
IL (1) IL99835A (index.php)
IN (1) IN172269B (index.php)
IS (1) IS1685B (index.php)
MX (1) MX9102516A (index.php)
NZ (1) NZ240817A (index.php)
WO (1) WO1992010166A1 (index.php)
ZA (1) ZA918489B (index.php)

Families Citing this family (90)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5580575A (en) * 1989-12-22 1996-12-03 Imarx Pharmaceutical Corp. Therapeutic drug delivery systems
US5469854A (en) * 1989-12-22 1995-11-28 Imarx Pharmaceutical Corp. Methods of preparing gas-filled liposomes
US20020150539A1 (en) 1989-12-22 2002-10-17 Unger Evan C. Ultrasound imaging and treatment
US5352435A (en) * 1989-12-22 1994-10-04 Unger Evan C Ionophore containing liposomes for ultrasound imaging
US5542935A (en) * 1989-12-22 1996-08-06 Imarx Pharmaceutical Corp. Therapeutic delivery systems related applications
US5205290A (en) 1991-04-05 1993-04-27 Unger Evan C Low density microspheres and their use as contrast agents for computed tomography
US5874062A (en) 1991-04-05 1999-02-23 Imarx Pharmaceutical Corp. Methods of computed tomography using perfluorocarbon gaseous filled microspheres as contrast agents
US6241967B1 (en) * 1992-10-16 2001-06-05 Andreas Sachse Process and device for the production of liquid, disperse systems
US5869305A (en) * 1992-12-04 1999-02-09 The University Of Pittsburgh Recombinant viral vector system
US6217849B1 (en) 1993-09-29 2001-04-17 Bracco Research S.A. Liposome suspensions as blood pool imaging contrast agents
US7083572B2 (en) 1993-11-30 2006-08-01 Bristol-Myers Squibb Medical Imaging, Inc. Therapeutic delivery systems
IL113139A0 (en) * 1994-03-28 1995-06-29 Nycomed Imaging As Diagnostic compositions comprising imaging agents encapsulated in liposomes
JPH10500999A (ja) * 1995-02-24 1998-01-27 ブラッコ リサーチ ソシエテ アノニム 血液プール画像形成造影剤としてのリポソーム懸濁液
US6521211B1 (en) 1995-06-07 2003-02-18 Bristol-Myers Squibb Medical Imaging, Inc. Methods of imaging and treatment with targeted compositions
US5738868A (en) * 1995-07-18 1998-04-14 Lipogenics Ltd. Liposome compositions and kits therefor
US6447800B2 (en) 1996-01-18 2002-09-10 The University Of British Columbia Method of loading preformed liposomes using ethanol
ATE345682T1 (de) 1996-05-01 2006-12-15 Imarx Pharmaceutical Corp In vitro verfahren zum einbringen von nukleinsäuren in eine zelle
US20020052310A1 (en) * 1997-09-15 2002-05-02 Massachusetts Institute Of Technology The Penn State Research Foundation Particles for inhalation having sustained release properties
US20010051131A1 (en) * 1996-06-19 2001-12-13 Evan C. Unger Methods for delivering bioactive agents
US5846517A (en) 1996-09-11 1998-12-08 Imarx Pharmaceutical Corp. Methods for diagnostic imaging using a renal contrast agent and a vasodilator
DE19639811A1 (de) * 1996-09-27 1998-04-02 Artur Herzog Dr Mesmer Verwendung einer Liposomenlösung zur Verstärkung der Wirksamkeit und/oder Verminderung der Toxizität von Arzneimitteln
GB9624918D0 (en) * 1996-11-29 1997-01-15 Nycomed Imaging As Particulate components
US6537246B1 (en) 1997-06-18 2003-03-25 Imarx Therapeutics, Inc. Oxygen delivery agents and uses for the same
WO1998044910A1 (en) 1997-04-09 1998-10-15 Philipp Lang NEW TECHNIQUE TO MONITOR DRUG DELIVERY NONINVASIVELY $i(IN VIVO)
US7452551B1 (en) 2000-10-30 2008-11-18 Imarx Therapeutics, Inc. Targeted compositions for diagnostic and therapeutic use
DE19731591C2 (de) * 1997-07-17 1999-09-16 Schering Ag Pharmazeutische Mittel enthaltend perfluoralkylgruppenhaltige Trijodaromaten und ihre Verwendung in der Tumortherapie und interventionellen Radiologie
US6306432B1 (en) * 1997-09-08 2001-10-23 Chiron Corporation High and low load formulations of IGF-I in multivesicular liposomes
US6106858A (en) * 1997-09-08 2000-08-22 Skyepharma, Inc. Modulation of drug loading in multivescular liposomes
EP1014946B1 (en) 1997-09-18 2010-04-07 Pacira Pharmaceuticals, Inc. Sustained-release liposomal anesthetic compositions
CA2309548A1 (en) 1997-11-14 1999-05-27 Skyepharma Inc. Production of multivesicular liposomes
US20010003580A1 (en) 1998-01-14 2001-06-14 Poh K. Hui Preparation of a lipid blend and a phospholipid suspension containing the lipid blend
DE19813773A1 (de) * 1998-03-27 1999-09-30 Clemens Unger Verfahren zur Herstellung von liposomalen Wirkstoffformulierungen
WO2000003660A1 (en) 1998-07-17 2000-01-27 Skyepharma, Inc. Biodegradable compositions for the controlled release of encapsulated substances
US6511676B1 (en) 1999-11-05 2003-01-28 Teni Boulikas Therapy for human cancers using cisplatin and other drugs or genes encapsulated into liposomes
AU2001266696A1 (en) 2000-06-02 2001-12-11 Bracco Research Usa Compounds for targeting endothelial cells
DE10121903A1 (de) * 2001-04-27 2002-10-31 Nimbus Biotechnologie Gmbh System für die Membranpermeationsmessung
CA2447990C (en) * 2001-05-31 2012-01-31 Skyepharma Inc. Encapsulation of nanosuspensions in liposomes and microspheres
JP3990880B2 (ja) * 2001-07-10 2007-10-17 キヤノン株式会社 ポリヒドロキシアルカノエート被覆リポソームの製造方法
CN1278675C (zh) * 2001-07-10 2006-10-11 佳能株式会社 含聚羟基烷醇酸酯的粒状体及其制备方法
EP1448165B1 (en) * 2001-11-13 2007-09-19 Celator Pharmaceuticals, Inc. Lipid carrier compositions and methods for improved drug retention
PT1443900E (pt) * 2001-11-13 2012-08-01 Celator Pharmaceuticals Inc Composições de veículo lipídico com estabilidade melhorada no sangue
US20030129224A1 (en) * 2001-11-13 2003-07-10 Paul Tardi Lipid carrier compositions and methods for improved drug retention
US20050129750A1 (en) * 2003-12-15 2005-06-16 Yu-Fang Hu Process for producing liposome suspension and product containing liposome suspension produced thereby
EP1547580A1 (en) * 2003-12-23 2005-06-29 MediGene Oncology GmbH Loading of a camptothecin drug into colloidal nanoparticles
EP1547582A1 (en) * 2003-12-23 2005-06-29 MediGene Oncology GmbH Method of producing lipid complexed camptothecin-carboxylate
CN1960707B (zh) 2004-06-03 2012-11-14 博莱科瑞士股份有限公司 用于治疗和/或诊断用途的脂质集合体
AU2005295072A1 (en) * 2004-10-08 2006-04-20 Alza Corporation Method of insertion of a lipid-linked moiety into a pre-formed lipid assembly using microwaves
CA2595731A1 (en) * 2005-01-26 2006-08-03 Celator Pharmaceuticals, Inc. Lipid carrier compositions with reduced polydispersity
US20070031342A1 (en) * 2005-06-22 2007-02-08 Nektar Therapeutics Sustained release microparticles for pulmonary delivery
ES2275443B1 (es) * 2005-11-30 2008-06-01 Italfarmaco, S.A. Procedimiento de preparacion de liposomas.
JP5080779B2 (ja) * 2006-10-25 2012-11-21 テルモ株式会社 リポソーム製剤の製造方法
US20090136937A1 (en) * 2007-05-09 2009-05-28 Coleman Matthew A Methods and systems for monitoring production of a target protein in a nanolipoprotein particle
WO2009067203A1 (en) * 2007-11-19 2009-05-28 Ceramoptec Industries, Inc. Pegylated compounds for age-related macular degeneration
US9688718B2 (en) 2008-01-11 2017-06-27 Lawrence Livermore National Security, Llc Nanolipoprotein particles comprising hydrogenases and related products, methods and systems
US9303273B2 (en) 2008-05-09 2016-04-05 Lawrence Livermore National Security, Llc Nanolipoprotein particles comprising a natural rubber biosynthetic enzyme complex and related products, methods and systems
US8883729B2 (en) * 2008-05-22 2014-11-11 Lawrence Livermore National Security, Llc Nanolipoprotein particles and related compositions, methods and systems
US9445975B2 (en) * 2008-10-03 2016-09-20 Access Business Group International, Llc Composition and method for preparing stable unilamellar liposomal suspension
EP2346532B1 (en) 2008-10-07 2020-10-07 Bracco Suisse SA Targeting construct comprising anti-polymer antibody and microvesicles binding to the same
EP2184054A1 (en) * 2008-11-08 2010-05-12 Lipoxen Technologies Limited Small Interfering RNA Delivery
US10151037B2 (en) 2009-01-12 2018-12-11 Lawrence Livermore National Security, Llc Electrochemical flow-cell for hydrogen production and nicotinamide dependent target reduction, and related methods and systems
WO2011038073A1 (en) 2009-09-23 2011-03-31 Formatech, Inc. Methods for the preparation of liposomes comprising docetaxel
US10143652B2 (en) 2009-09-23 2018-12-04 Curirx Inc. Methods for the preparation of liposomes
EP2663327A4 (en) 2011-01-13 2015-12-02 Variation Biotechnologies Inc COMPOSITIONS AND METHOD FOR THE TREATMENT OF VIRUS INFECTIONS
US9644038B2 (en) 2011-12-21 2017-05-09 The Regents Of The University Of California Apolipoprotein nanodiscs with telodendrimer
CA2894442C (en) 2012-01-12 2020-01-21 Variation Biotechnologies Inc. Compositions and methods for treating viral infections
WO2013111012A2 (en) * 2012-01-27 2013-08-01 Variation Biotechnologies, Inc. Methods and compositions for therapeutic agents
US9801862B2 (en) 2013-11-05 2017-10-31 Gustavo A. Garcia-Sánchez Immunosuppressive treatments, formulations and methods
ES2836772T3 (es) 2014-04-30 2021-06-28 Fujifilm Corp Composición liposomal y método para producirla
EP3138558B1 (en) * 2014-04-30 2023-06-07 FUJIFILM Corporation Liposome composition and production method therefor
MX2017008721A (es) 2014-12-31 2017-11-17 Lantheus Medical Imaging Inc Composiciones de microesferas de gas encapsulado en lipidos y metodos relacionados.
US11376218B2 (en) 2015-05-04 2022-07-05 Versantis AG Method for preparing transmembrane pH-gradient vesicles
WO2017035326A1 (en) 2015-08-25 2017-03-02 Lawrence Livermore National Security, Llc Stable nanolipoprotein particles and related compositions methods and systems
US11279749B2 (en) 2015-09-11 2022-03-22 Lawrence Livermore National Security, Llc Synthetic apolipoproteins, and related compositions methods and systems for nanolipoprotein particles formation
EP3372223B1 (en) * 2015-11-02 2024-04-17 FUJIFILM Corporation Liposome composition and method for producing same
IL296876B2 (en) 2016-05-04 2025-05-01 Lantheus Medical Imaging Inc Methods and devices for preparing ultrasound contrast agents
US9789210B1 (en) 2016-07-06 2017-10-17 Lantheus Medical Imaging, Inc. Methods for making ultrasound contrast agents
CA3032810A1 (en) 2016-08-02 2018-02-08 Curirx Inc. Methods for the preparation of liposomes
US11207422B2 (en) 2017-05-02 2021-12-28 Lawrence Livermore National Security, Llc MOMP telonanoparticles, and related compositions, methods and systems
US12083223B2 (en) 2017-05-02 2024-09-10 Lawrence Livermore National Security, Llc Nanolipoprotein particles and related compositions methods and systems for loading RNA
TWI882475B (zh) 2018-06-20 2025-05-01 日商富士軟片股份有限公司 包含內含吉西他濱之脂質體組成物及免疫檢查點抑制劑之組合醫藥
MX2021015667A (es) * 2019-06-28 2022-04-18 Univ Texas Metodo de reconstitucion de anamicina liposomica.
US11980636B2 (en) 2020-11-18 2024-05-14 Jazz Pharmaceuticals Ireland Limited Treatment of hematological disorders
US11033495B1 (en) 2021-01-22 2021-06-15 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11357727B1 (en) 2021-01-22 2022-06-14 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US12151024B2 (en) 2021-01-22 2024-11-26 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11278494B1 (en) 2021-01-22 2022-03-22 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
GB2627096A (en) 2021-10-14 2024-08-14 Pacira Pharmaceuticals Inc Bupivacaine multivesicular liposome formulations and uses thereof
US12251472B1 (en) 2024-05-20 2025-03-18 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US12280149B1 (en) 2024-05-20 2025-04-22 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US12156940B1 (en) 2024-05-20 2024-12-03 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5186117A (en) * 1975-01-27 1976-07-28 Tanabe Seiyaku Co Johoseibiryushiseizainoseiho
CA1270198A (en) * 1984-08-08 1990-06-12 Marcel B. Bally Encapsulation of antineoplastic agents in liposomes
JPS6150912A (ja) * 1984-08-16 1986-03-13 Shionogi & Co Ltd リポソ−ム製剤の製造法
JPS63211222A (ja) * 1987-02-27 1988-09-02 Terumo Corp リポソ−ムの製法
US4963297A (en) * 1987-12-22 1990-10-16 The Liposome Company, Inc. Spontaneous vesticulation of multilamellar liposomes
CH672733A5 (index.php) * 1987-05-22 1989-12-29 Bracco Ind Chimica Spa
US4870160A (en) * 1987-08-19 1989-09-26 Regents Of The University Of Minnesota Polypeptides with laminin activity
IE63518B1 (en) * 1987-11-18 1995-05-03 Vestar Inc Multiple step entrapment/loading procedure for preparing lipophilic drug-containing liposomes
EP0393145A4 (en) * 1987-12-22 1991-09-11 The Liposome Company, Inc. Spontaneous vesiculation of multilamellar liposomes
EP0414806B1 (en) * 1988-05-20 1994-07-20 The Liposome Company, Inc. High ratio active agent:lipid complex
IL91664A (en) * 1988-09-28 1993-05-13 Yissum Res Dev Co Ammonium transmembrane gradient system for efficient loading of liposomes with amphipathic drugs and their controlled release

Also Published As

Publication number Publication date
ES2081605T3 (es) 1996-03-16
JP3241720B2 (ja) 2001-12-25
ZA918489B (en) 1992-07-29
IL99835A0 (en) 1992-08-18
DK0514523T3 (da) 1996-01-29
ATE131724T1 (de) 1996-01-15
AU9062991A (en) 1992-07-08
DE69115682D1 (de) 1996-02-01
EP0514523A1 (en) 1992-11-25
NZ240817A (en) 1993-01-27
HUT62458A (en) 1993-05-28
IE72163B1 (en) 1997-03-26
IS3773A7 (is) 1992-06-12
KR920703014A (ko) 1992-12-17
GR3018506T3 (en) 1996-03-31
CA2072559A1 (en) 1992-06-12
IS1685B (is) 1998-02-24
AU635456B2 (en) 1993-03-18
JPH05504150A (ja) 1993-07-01
EP0514523B1 (en) 1995-12-20
IE914289A1 (en) 1992-06-17
CA2072559C (en) 1997-03-18
WO1992010166A1 (en) 1992-06-25
KR0137783B1 (ko) 1998-05-15
IN172269B (index.php) 1993-05-29
US5393530A (en) 1995-02-28
IL99835A (en) 1995-11-27
DE69115682T2 (de) 1996-05-15

Similar Documents

Publication Publication Date Title
MX9102516A (es) Metodo para fabricar liposomas de una capacidad de atrape mejorada hacia las substancias extrañas que se van a encapsular.
DK433484D0 (da) Medikamentholdigt lipidvesikelpraeparat
ES2118677T1 (es) Una composicion que comprende un agente activo disuelto en un vehiculo vitrificante y un procedimiento para su preparacion.
DE3867637D1 (de) Paucilamellare lipidvesikel.
PL339768A1 (en) Method of encapsulating aromatic and taste giving substances by controllable delivery of water into microcapsules
EP0171710A3 (en) Process for preparing liposome composition
ES2039759T5 (es) Preparados estables, dispersables en agua fria.
ES2171261T3 (es) Conservantes de la madera.
ES8700931A1 (es) Procedimiento para preparar composiciones de uso cosmetico o farmaceutico a base de unas esferulas lipidicas que contienen un polimero de poliamida.
AU2831984A (en) Porphyrin derivatives and their use as labels in fluorescence immuno-assays
NO901852D0 (no) Fremgangsmaate for fremstilling av liposomer.
AP9400683A0 (en) Vaccines.
SE7713946L (sv) Sett for framstellning av en massa av i en fysiologisk losning suspenderade belastade celler
EP0474790A4 (en) Media for cell growth and method for making them
DE3476338D1 (en) Preparation of unilamellar large diameter liposomes, their pharmaceutical application in view of the encapsulation of the active principle for sustained release, and device therefor
ES2194273T3 (es) Regulacion de la produccion de inmunoglobulinas por la interleucina-9.
DE69027686D1 (de) Trennung von verschiedenen zellen
ES2174143T3 (es) Procedimiento para preparar vesiculas cerradas mediante rehidratacion de vesiculas deshidratadas.
KR920002165A (ko) 리포좀 생성물
ES2117267T3 (es) Metodo para encapsular sustancias en biocapsulas.
Utz Avignon Days
RU94036320A (ru) Среда для заключения и хранения гистологических срезов
ES2106495T3 (es) Mejoras en la eficacia de los medicamentos.
LIN et al. Multiphoton-multiphonon theory of laser-stimulated surface processes[Interim Technical Report]
Bosin et al. Mechanism of Influence of Forest Dislocation Density on Mobility of Twin Bondaries in Zn Crystals. I. The Effect of Pyramidal Forest Dislocations

Legal Events

Date Code Title Description
FG Grant or registration
MM Annulment or lapse due to non-payment of fees